ArticleFrontiers in endocrinology2026
Metabolomic profiling refines cardiovascular risk stratification beyond SCORE2-diabetes in patients with concurrent type 2 diabetes and pulmonary dysfunction.
Meili Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.